Results 31 to 40 of about 442,632 (268)

The physiopathology of lipoprotein a

Frontiers in Bioscience, 2010
Lipoprotein(a) (also called Lp(a)) is a lipoprotein subclass. Different studies have identified Lp(a) as a putative risk factor for atherosclerotic diseases such as coronary artery disease and stroke. The physiological role of Lp(a) in humans is still unclear, but it seems that individuals with low concentrations of plasma Lp(a) manifest no deficiency ...
GALVANO, Fabio, MALAGUARNERA M, VACANTE M, MOTTA, Massimo, RUSSO C, MALAGUARNERA M, D'ORAZIO N, MALAGUARNERA, Lucia   +7 more
openaire   +3 more sources

Assessing the Accuracy of Estimated Lipoprotein(a) Cholesterol and Lipoprotein(a)‐Free Low‐Density Lipoprotein Cholesterol

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022
Background Accurate measurement of the cholesterol within lipoprotein(a) (Lp[a]‐C) and its contribution to low‐density lipoprotein cholesterol (LDL‐C) has important implications for risk assessment, diagnosis, and treatment of atherosclerotic ...
Weili Zheng, Michael Chilazi, Jihwan Park, Vasanth Sathiyakumar, Leslie J. Donato, Jeffrey W. Meeusen, Mariana Lazo, Eliseo Guallar, Krishnaji R. Kulkarni, Allan S. Jaffe, Raul D. Santos, Peter P. Toth, Steven R. Jones, Seth S. Martin   +13 more
doaj   +1 more source

Contemporary patterns of lipoprotein(a) testing and associated clinical care and outcomes

American Journal of Preventive Cardiology, 2023
Objective: Elevated lipoprotein(a) [Lp(a)] is associated with atherosclerotic cardiovascular disease, yet little is known about Lp(a) testing patterns in real-world practice.
Michelle D. Kelsey, Hillary Mulder, Karen Chiswell, Zachary M. Lampron, Ester Nilles, Jacquelyn P. Kulinski, Parag H. Joshi, W. Schuyler Jones, Alanna M. Chamberlain, Thorsten M. Leucker, Wenke Hwang, M. Wesley Milks, Anuradha Paranjape, Jihad S. Obeid, MacRae F. Linton, Shia T. Kent, Eric D. Peterson, Emily C. O'Brien, Neha J. Pagidipati   +18 more
doaj   +1 more source

Low‐Density Lipoprotein Cholesterol Corrected for Lipoprotein(a) Cholesterol, Risk Thresholds, and Cardiovascular Events

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2020
Background Conventional "low‐density lipoprotein cholesterol (LDL‐C)" assays measure cholesterol content in both low‐density lipoprotein and lipoprotein(a) particles.
Peter Willeit, Calvin Yeang, Patrick M. Moriarty, Lena Tschiderer, Stephen A. Varvel, Joseph P. McConnell, Sotirios Tsimikas   +6 more
doaj   +1 more source

Lp(a) and inflammation: a new insight into atherosclerosis

Clinical and Translational Discovery, 2023
Background Lipid‐lowering therapy is of utmost importance in both primary and secondary prevention of atherosclerotic cardio vascular disease (ASCVD).
Hangyu Pan, Kexin Hu, Qiao Wu, Yan Tu, Zhigang Guo   +4 more
doaj   +1 more source

Assessment of the Utilization of Lipoprotein (a) and its Relationship with Cardiovascular Outcomes: A Retrospective Cohort Study from a Public Hospital in New York City

Heart Views
Introduction: Lipoprotein (a) [Lp(a)] is an independent genetic risk factor for atherosclerotic cardiovascular disease (ASCVD) and is associated with an increased risk of heart failure (HF), multiple vascular and valvular abnormalities and is closely ...
Maisha Maliha, Natalia Nazarenko, Sanjana Nagraj, Vikyath Satish, Amrin Kharawala, Pawel Borkowski, Vibhor Garg, Tinatin Saralidze, Dimitrios Karamanis, Leonidas Palaiodimos   +9 more
doaj   +1 more source

The Comparison of the Associations of Lipoprotein(a) and the Atherogenic Index of Plasma With Coronary Artery Calcification in Patients Without High LDL-C: A Comparative Analysis

Journal of Lipid and Atherosclerosis, 2023
Objective Lipoprotein(a) (Lp[a]) and the atherogenic index of plasma (AIP) have been reported as predictive markers of coronary artery calcium (CAC).
Seung-Pyo Hong, Chang-Yeon Kim, Hae Won Jung   +2 more
doaj   +1 more source

Reciprocal control of viral infection and phosphoinositide dynamics

FEBS Letters, EarlyView.
Phosphoinositides, although scarce, regulate key cellular processes, including membrane dynamics and signaling. Viruses exploit these lipids to support their entry, replication, assembly, and egress. The central role of phosphoinositides in infection highlights phosphoinositide metabolism as a promising antiviral target.
Marie Déborah Bancilhon, Bruno Mesmin
wiley   +1 more source

Can Lp(a) become the next A1C? A case for digital health management tools to overcome inertia to Lipoprotein (a) testing

Frontiers in Cardiovascular Medicine
Despite its known correlations with risk of cardiovascular disease, awareness and testing for Lipoprotein (a) lags that of other serological markers with estimates that less than 1% of the US population have undergone screening.
Christof Wedemeyer, Martin Peters, Graham Jones, Graham Jones   +3 more
doaj   +1 more source

Case report: lipoprotein apheresis reduces the risk of cardiovascular events and prolongs pregnancy in a woman with severely elevated lipoprotein(a), cardiovascular disease, and a high risk of preeclampsia

Frontiers in Medicine, 2023
BackgroundPreeclampsia is a common and serious pregnancy-induced disease, with potential severe maternal and fetal complications. Recently, an increased lipoprotein (a) (Lp[a]) concentration, an important factor in cardiovascular diseases (CVDs ...
Joanna Marlȩga-Linert, Katarzyna Wartecka-Zielińska, Dariusz Wydra, Marcin Fijałkowski, Marcin Gruchała, Agnieszka Mickiewicz   +5 more
doaj   +1 more source